Views & Analysis

Views & Analysis
Neale Belson

Pharma’s response to COVID: GSK

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future.

R&D
Dangerous data delays – a real-time problem

Dangerous data delays – a real-time problem

Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candid